Health

Healthcare Economist Unbiased Analysis of Today’s Healthcare Issues

  • Links
    by Jason Shafrin on February 20, 2026 at 6:07 am

    FDA reverses its decision and will now review the Moderna flu vaccine. Could Australia be a model for FDA reform? “Pharma signals it’s done negotiating” Giant viruses. Hairy ball theorem.

  • Decoding the PBM Reform Provisions of the 2026 Consolidated Appropriations Act
    by Jason Shafrin on February 19, 2026 at 5:24 am

    After years of legislative debate, Congress has formally codified PBM reform into federal statute. Tucked within the Consolidated Appropriations Act, 2026 (H.R. 7148), signed on February 3, 2026 are structural mandates that will reshape Pharmacy Benefit Manager (PBM) operations in Medicare Part D and the commercial sector by 2028. The legislation targets three primary pillars:…

  • How has private equity hospital ownership impact the quality of labor & delivery care?
    by Jason Shafrin on February 18, 2026 at 5:23 am

    The number of hospitals owned by private equity (PE) firms has increased in recent years. One key question is how increased PE ownership has impact quality of care. To answer the question, a Jiao 2025 Health Services Research paper used claims Medicaid claims data–specifically data from the Transformed Medicaid Statistical Information System (T-MSIS) and Medicaid…

  • Something Democrats and Republicans agree on: Dislike for prior authorization
    by Jason Shafrin on February 17, 2026 at 1:54 am

    That is the findings from a KFF Health Tracking Poll out this month. The survey examines which aspects of accessing care and health insurance are the biggest problem for insured adults. The survey finds that 69% of adults believe prior authorization is a burden. Specifically, the survey asks “When it comes to getting health care,…

  • Friday Links
    by Jason Shafrin on February 13, 2026 at 2:45 pm

    Expert opinions: Will MFN reduce US drug prices? Robots in maternity care. What drives company decisions on new medicine launches and UK investment? Incorporating dynamic pricing into HEOR models (dynamicpv) Tale of 2 value sets. How to handle the lows? Honesty. Integrity in journalism: Giannis edition.